Suchergebnisse - "Thompson, John L"

PubPharm (125)

41

Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin

enthalten in: The American journal of cardiology | 2015

von Ye, S. | Cheng, B. | Lip, G. | +19

42

Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm : Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy

enthalten in: Circulation. Heart failure | 2015

von Homma, S. | Thompson, J. | Qian, M. | +118

43

Association of quality of life with anticoagulant control in patients with heart failure : the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trial

enthalten in: International journal of cardiology | 2014

von Shaffer, J. | Thompson, J. | Cheng, B. | +16

44

Designing clinical trials for dystonia

enthalten in: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics | 2014

von Galpern, W. | Coffey, C. | Albanese, A. | +13

45

Cognitive function in ambulatory patients with systolic heart failure : insights from the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial

enthalten in: PloS one | 2014

von Graham, S. | Ye, S. | Qian, M. | +118

46

Recurrent stroke in the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial

enthalten in: Cerebrovascular diseases (Basel, Switzerland) | 2014

von Pullicino, P. | Qian, M. | Sacco, R. | +115

47

Designing Clinical Trials for Dystonia

enthalten in: Neurotherapeutics | 2013

von Galpern, W. | Coffey, C. | Albanese, A. | +13

48

Benefit of warfarin compared with aspirin in patients with heart failure in sinus rhythm : a subgroup analysis of WARCEF, a randomized controlled trial

enthalten in: Circulation. Heart failure | 2013

von Homma, S. | Thompson, J. | Sanford, A. | +18

49

Body mass index (BMI) as predictor of ALSFRS-R score decline in ALS patients

enthalten in: Amyotrophic lateral sclerosis & frontotemporal degeneration | 2013

von Reich-Slotky, R. | Andrews, J. | Cheng, B. | +4

50

Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy

enthalten in: Stroke | 2013

von Longstreth, W. | Kronmal, R. | Thompson, J. | +10